## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.3% below STRENGTH zone (3.0-6.0%); PEG 1.53 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($170.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 1)

**1. The Truth About Texas Instruments Inc: Why Everyone Is Suddenly Paying Attention**
- Source: AD HOC NEWS | 20260102T113249 | Somewhat-Bullish | Relevance: 100%
- Texas Instruments Inc (TXN) is a foundational technology company, quietly powering various modern electronics through its analog and embedded chips. While not a "hype" stock like some AI companies, TXN is highlighted as a stable, long-term investment due to its strong free cash flow, dividend history, and control over its manufacturing. Investors looking for a reliable "picks and shovels" play in the tech sector, rather than viral growth, may find TXN to be a valuable addition to their portfolio.

**2. The Truth About Texas Instruments Inc: Why Everyone Is Suddenly Paying Attention**
- Source: AD HOC NEWS | 20260102T110917 | Bullish | Relevance: 100%
- Texas Instruments Inc (TXN) is a quiet powerhouse in the semiconductor industry, specializing in analog and embedded chips crucial for AI, automotive, and industrial applications. While not a "meme stock," it offers long-term stability, strong cash flow, and dividends, making it attractive for investors seeking reliable growth rather than short-term hype. The article compares TXN to competitors like Analog Devices and emphasizes its foundational role in modern technology, contrasting it with high-volatility AI stocks.

**3. Texas Instruments stock today: TXN slides into 2026 after year-end chip selloff**
- Source: ts2.tech | 20260102T100819 | Bearish | Relevance: 100%
- Texas Instruments' stock (TXN) slipped into 2026, ending 2025 down 1.1% on the final trading day, extending a four-session losing streak. The decline in TXN, considered a bellwether for cyclical demand, raises questions about the stabilization of the analog chip cycle ahead of upcoming earnings reports. Investors are eagerly awaiting demand signals from industrial and automotive sectors, as well as commentary on inventories and gross margins, with key economic data also on the horizon to set the market's tone for growth and rates in early 2026.

**4. The "Harvest Year" Begins: Why Institutional Giants Are Betting Big on Texas Instruments for 2026**
- Source: FinancialContent | 20260101T102300 | Bullish | Relevance: 100%
- Institutional investors are significantly increasing their stakes in Texas Instruments (TXN), signaling strong confidence in the company's "big bet" on internal manufacturing and 300mm wafer capacity. This surge in investment follows the successful completion and high-volume production at its SM1 fab in Sherman, validating TXN's long-term strategy of vertical integration and domestic manufacturing. The market anticipates a "harvest phase" for TXN, positioning it as a high-yield manufacturing powerhouse and a fundamental pillar of the global technological infrastructure.

**5. Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land**
- Source: ts2.tech | 20251231T020852 | Neutral | Relevance: 100%
- Texas Instruments (TXN) shares were little changed following news that Weebit Nano licensed its ReRAM non-volatile memory IP to the chipmaker for embedded processing chips. This deal is significant for automotive and industrial markets that require persistent data storage, sectors where TI is a major player. The muted stock reaction reflects a slow trading day on Wall Street and came as investors digested minutes from the Federal Reserve's December meeting.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Truist Securiti | $195 | $175 | +11% |
| 2025-12-15 | Goldman Sachs | $156 | $200 | -22% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Truist Securiti | main | Hold |
| 2025-12-15 | Goldman Sachs | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 6 ($1.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +2.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.53 elevated, pricing in significant growth expectations. Forward P/E 28.9x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Insider selling cluster ($2.0M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $161.4B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.53 |
| Forward P/E | 28.9 |
| Current P/E | 32.4 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to 1.3% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.7pp (needs >3.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram bearish (-0.66), momentum weakening. RSI neutral at 56. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.26% (CS: 63) | Neutral |
| RSI_14 | 55.6 | Neutral |
| MACD Histogram | -0.66 | Bearish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 1.048x | Above |
| vs SMA200 | 0.978x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $177.52
- **Stop Loss:** $170.02 (4.2% risk)
- **Target:** $185.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 160
- **Position Value:** $28,403.20
- **Portfolio %:** 28.40%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*